The Innovative Medicines Initiative (IMI) has launched its 20th Call for proposals on 21 January 2020. It is a standard, two-stage call for proposals. Deadline for stage one is 21 April 2020.
The new call includes the following topics:
- Early diagnosis, prediction of radiographic outcomes and development of rational, personalised treatment strategies to improve long-term outcomes in psoriatic arthritis
- Innovations to accelerate vaccine development and manufacture
- Academia and industry united innovation and treatment for tuberculosis (UNITE4TB)
- Tumour plasticity
- Proton versus photon therapy for oesophageal cancer – a trimodality strategy
- Handling of protein drug products and stability concerns